View Post

GLP-1 Drugs and Medical Aesthetics – The New Dimension – Asrar Qureshi’s Blog Post #1111

GLP-1 receptor agonists like semaglutide and tirzepatide are revolutionizing weight management and reshaping the medical aesthetics industry. As weight loss leads to aesthetic concerns, there’s a growing demand for treatments. Aesthetic providers must adapt to new patient demographics by offering personalized care and emphasizing holistic well-being, ensuring emotional support alongside physical transformations.
Share
View Post

New Drug Modalities – Asrar Qureshi’s Blog Post 1047

Asrar Qureshi’s blog discusses the Boston Consulting Group’s second annual report on the growth of new drug modalities. It highlights advancements in antibodies, recombinant products, cell therapies, gene therapies, and mRNA applications, emphasizing their implications for biopharma companies and patient care. The future of these modalities depends on their unique benefits and market speed.
Share